Key facts
- Equals 5’s last known valuation is $14.5M (Feb 2025).
- It has raised $3.0M; the latest was Later Stage VC ($3.0M) in Feb 2025.
- Notable investors include Baleon Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Equals 5
- ·The full record, as it builds
Funding rounds
No funding rounds for Equals 5 are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Equals 5
Developer of a healthcare marketing tool designed to measure online social media engagement scores and behavior. The company's tool uses proprietary algorithms that assist with social media advertising and management of social media with features for CRM integration, real-time dashboard management, reporting and patient targeting, enabling pharma marketers to increase patient connections and nurture those relationships to form long-term relationships.
- Sector
- Information Technology
- HQ
- New York, NY, United States
- Founded
- 2020
- Employees
- 29
- Website
- equals5.com/
- Ownership
- Privately Held (backing)
Equals 5 doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Equals 5 shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Equals 5 in its N-PORT filings yet. We sweep new filings monthly.